Le Lézard
Classified in: Health
Subject: TRI

The Herpes Vaccine in Development, and What to do While You Wait


SARASOTA, Fla., Nov. 21, 2017 /PRNewswire/ -- "Herpes is one of those virus that's just amazing at evading our immune system," says Harvey M. Friedman, a professor at the University of Pennsylvania School of Medicine. [1] [2] How does the virus do it?  His team discovered that HSV produces a pair of proteins that stop the human immune system from producing the HSV antibodies, those that identify and help destroy the virus.  Most herpes vaccines prevent the virus from entering the cells. [2] The new vaccine, developed by Friedman, attacks the viral molecules that help the virus hide from the immune system.  Friedman notes that the new vaccine, "... keeps the virus from hiding from those antibodies". [2] So far, the vaccine has been tested on monkeys (macaque) and guinea pigs.  Monkey and humans have different HSV symptoms.  The researchers found the monkey's immune systems responded in the way they anticipated.  The vaccine was very effective in the guinea pigs.  It protected most of the guinea pigs from herpes, and reduced the presence of the virus in the infected guinea pigs.  Humans and guinea pigs have similar HSV symptoms.

"I really do think this is more promising than other vaccine research out there," Friedman said. "I've never seen anything published that comes close to our efficacy." [2] Friedman says that the vaccine is groundbreaking since it prevents the virus from evading the immune system. He notes, "And that could really open up the field, not just for herpes. There are so many chronic, persistent, recurrent viruses that we could use this strategy on." [2]

About Gene-Eden-VIR and Novirin

For those who are already infected, or prefer natural treatments over vaccines, Lilac Corp suggests using Gene-Eden-VIR or Novirin, safe and effective natural herpes treatments already on the market.  Two clinical studies, published in the medical journals Drug Design, Development and Therapy and Clinical and Translational Medicine, showed that Gene-Eden-VIR and Novirin decreased genital herpes outbreaks without any side effects.  One of the studies also showed that the herbal treatment are better than acyclovir, valacyclovir, and famciclovir, the three leading drugs used in the treatment of genital herpes. [3] [4]  

For more information on the studies, visit http://cbcd.net/.  To order Gene-Eden-VIR or Novirin, visit: http://no-viren.com/.

About Lilac Corp

Lilac Corp specializes in the development of biology based patent protected dietary supplements. Currently, Lilac Corp is selling two products: Gene-Eden-VIR and Novirin. Lilac Corp ships its products to more than 100 countries around the world. What makes Lilac Corp special is that all its products are tested in clinical studies that follow FDA guidelines. To ensure transparency, the results of the clinical studies are published in leading scientific journals. All of Lilac Corp's products have a 90 day money back guarantee.

Media contact:
Mark Richards
585-250-9999 
http://no-viren.com/

[1] Awasthi S, et al. An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs. PLoS Pathog. 
[2] https://www.popsci.com/herpes-vaccine-study
[3] Polansky H, Javaherian A, Itzkovitz E. Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir. Drug Des Devel Ther. 2016 Aug 29;10:2713-22
[4] Polansky H, Itzkovitz E, Javaherian A. Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases. Clin Transl Med. 2016 Dec;5(1):40. Epub 2016 Oct 20.

SOURCE Lilac Corp


These press releases may also interest you

at 12:05
VirtualHealth is excited to share that its HELIOS platform was named the winner of a Bronze Stevie® Award in the Healthcare Technology Solution category in The 22nd Annual American Business Awards® today. More than 3,700 nominations were submitted...

at 12:02
On May 1, 2024, Toronto Public Health (TPH) will host Diverse Dialogues: Stigma & Breaking Barriers. The event will bring together distinguished speakers to explore the challenging and thought-provoking topic about how negative labels and biases...

at 11:56
As the demand for cosmetic procedures continues to rise, patients are seeking more advanced and effective options for achieving a youthful and rejuvenated appearance. In response to this, Dr. Ronald Demeo has introduced the Next Level Deep Plane Face...

at 11:50
Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company") today reported its 2023 consolidated annual financial results, as of December 31, 2023, and provided financial information (unaudited)...

at 11:34
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the...

at 11:25
TimelyCare, higher education's most trusted virtual health and well-being provider, has earned recognition as one of the World's Best Digital Health Companies by Newsweek, and has been awarded five Top Workplaces Awards for culture excellence....



News published on and distributed by: